TransMedics Group, Inc. Operating Income
TransMedics Group, Inc. (TMDX) reported Operating Income of $23.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-04
- TransMedics Group, Inc. operating income (loss) for the quarter ending 2026-06-30 was $23.74M, a 35.09% decline year-over-year.
- TransMedics Group, Inc. operating income (loss) for the quarter ending 2026-03-31 was $13.30M, a 51.55% decline year-over-year.
- TransMedics Group, Inc. operating income (loss) for the quarter ending 2025-12-31 was $21.27M, a 146.10% increase year-over-year.
- TransMedics Group, Inc. operating income (loss) for the quarter ending 2025-09-30 was $23.30M, a 493.93% increase year-over-year.
- TransMedics Group, Inc. operating income (loss) for fiscal 2025 was $108.58M, a 189.59% increase from fiscal 2024.
- TransMedics Group, Inc. operating income (loss) for fiscal 2024 was $37.50M.
- TransMedics Group, Inc. operating income (loss) for fiscal 2023 was -$28.73M.
- TransMedics Group, Inc. operating income (loss) for fiscal 2022 was -$31.44M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.74M 10-Q · filed 2026-08-04 | $37.03M 10-Q · filed 2026-08-04 | $58.31M derived: sum of 3 quarters · filed 2026-08-04 | $81.61M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $13.30M 10-Q · filed 2026-05-05 | $34.57M derived: sum of 2 quarters · filed 2026-05-05 | $57.87M derived: sum of 3 quarters · filed 2026-05-05 | $94.44M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $21.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $44.57M derived: sum of 2 quarters · filed 2026-02-24 | $81.14M derived: sum of 3 quarters · filed 2026-08-04 | $108.58M 10-K · filed 2026-02-24 |
| 2025-09-30 | $23.30M 10-Q · filed 2025-10-29 | $59.87M derived: sum of 2 quarters · filed 2026-08-04 | $87.31M 10-Q · filed 2025-10-29 | $95.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $36.57M 10-Q · filed 2026-08-04 | $64.01M 10-Q · filed 2026-08-04 | $72.65M derived: sum of 3 quarters · filed 2026-08-04 | $76.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $27.44M 10-Q · filed 2026-05-05 | $36.09M derived: sum of 2 quarters · filed 2026-05-05 | $40.01M derived: sum of 3 quarters · filed 2026-05-05 | $52.52M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $12.57M derived: sum of 2 quarters · filed 2026-02-24 | $25.07M derived: sum of 3 quarters · filed 2026-02-24 | $37.50M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.92M 10-Q · filed 2025-10-29 | $16.43M derived: sum of 2 quarters · filed 2025-10-29 | $28.85M 10-Q · filed 2025-10-29 | $31.45M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $12.51M 10-Q · filed 2025-07-30 | $24.93M 10-Q · filed 2025-07-30 | $27.53M derived: sum of 3 quarters · filed 2026-02-24 | -$803.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $12.42M 10-Q · filed 2025-05-08 | $15.02M derived: sum of 2 quarters · filed 2026-02-24 | -$13.31M derived: sum of 3 quarters · filed 2026-02-24 | -$14.22M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$25.73M derived: sum of 2 quarters · filed 2026-02-24 | -$26.64M derived: sum of 3 quarters · filed 2026-02-24 | -$28.73M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$28.34M 10-Q · filed 2024-10-29 | -$29.24M derived: sum of 2 quarters · filed 2024-10-29 | -$31.33M 10-Q · filed 2024-10-29 | -$38.11M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$906.00K 10-Q · filed 2024-08-01 | -$3.00M 10-Q · filed 2024-08-01 | -$9.77M derived: sum of 3 quarters · filed 2025-02-27 | -$15.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$2.09M 10-Q · filed 2024-05-02 | -$8.87M derived: sum of 2 quarters · filed 2025-02-27 | -$14.41M derived: sum of 3 quarters · filed 2025-02-27 | -$24.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$6.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$12.32M derived: sum of 2 quarters · filed 2025-02-27 | -$22.07M derived: sum of 3 quarters · filed 2025-02-27 | -$31.44M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$5.54M 10-Q · filed 2023-11-08 | -$15.29M derived: sum of 2 quarters · filed 2023-11-08 | -$24.66M 10-Q · filed 2023-11-08 | -$35.99M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$9.74M 10-Q · filed 2023-08-04 | -$19.11M 10-Q · filed 2023-08-04 | -$30.44M derived: sum of 3 quarters · filed 2024-02-27 | -$42.17M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$9.37M 10-Q · filed 2023-05-04 | -$20.70M derived: sum of 2 quarters · filed 2024-02-27 | -$32.42M derived: sum of 3 quarters · filed 2024-02-27 | -$42.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$11.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$23.05M derived: sum of 2 quarters · filed 2024-02-27 | -$32.92M derived: sum of 3 quarters · filed 2024-02-27 | -$39.43M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$11.72M 10-Q · filed 2022-11-04 | -$21.59M derived: sum of 2 quarters · filed 2022-11-04 | -$28.10M 10-Q · filed 2022-11-04 | -$34.00M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$9.87M 10-Q · filed 2022-08-03 | -$16.38M 10-Q · filed 2022-08-03 | -$22.27M derived: sum of 3 quarters · filed 2022-08-03 | -$26.88M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | -$6.51M 10-Q · filed 2022-05-05 | -$12.40M derived: sum of 2 quarters · filed 2022-05-05 | -$17.01M derived: sum of 3 quarters · filed 2022-05-05 | -$24.87M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$5.90M 10-K · filed 2021-03-11 | -$10.51M derived: sum of 2 quarters · filed 2021-11-09 | -$18.37M derived: sum of 3 quarters · filed 2021-11-09 | -$26.38M 10-K · filed 2021-03-11 |
| 2020-09-30 | -$4.61M 10-Q · filed 2021-11-09 | -$12.47M derived: sum of 2 quarters · filed 2021-11-09 | -$20.49M 10-Q · filed 2021-11-09 | -$29.18M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$7.86M 10-Q · filed 2021-08-06 | -$15.88M 10-Q · filed 2021-08-06 | -$24.57M derived: sum of 3 quarters · filed 2021-08-06 | -$31.81M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$8.02M 10-K · filed 2021-03-11 | -$16.71M derived: sum of 2 quarters · filed 2021-05-07 | -$23.95M derived: sum of 3 quarters · filed 2021-05-07 | -$31.66M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | -$8.69M 10-K · filed 2021-03-11 | -$15.94M derived: sum of 2 quarters · filed 2021-03-11 | -$23.64M derived: sum of 3 quarters · filed 2021-03-11 | -$29.60M 10-K · filed 2021-03-11 |
| 2019-09-28 | -$7.24M 10-K · filed 2021-03-11 | -$14.95M derived: sum of 2 quarters · filed 2021-03-11 | -$20.91M 10-Q · filed 2019-11-08 | -$27.27M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-29 | -$7.71M 10-K · filed 2021-03-11 | -$13.67M 10-Q · filed 2020-08-07 | -$20.03M derived: sum of 3 quarters · filed 2021-03-11 | -$23.97M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-30 | -$5.96M 10-K · filed 2021-03-11 | -$12.32M derived: sum of 2 quarters · filed 2021-03-11 | -$16.26M derived: sum of 3 quarters · filed 2021-03-11 | -$21.42M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-29 | -$6.36M 10-K · filed 2020-03-17 | -$10.30M derived: sum of 2 quarters · filed 2020-03-17 | -$15.46M derived: sum of 3 quarters · filed 2020-03-17 | -$20.24M 10-K · filed 2020-03-17 |
| 2018-09-29 | -$3.94M 10-K · filed 2020-03-17 | -$9.10M derived: sum of 2 quarters · filed 2020-03-17 | -$13.88M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$5.16M 10-K · filed 2020-03-17 | -$9.94M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$4.78M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |